Approach

Nano drug delivery systems are promising and shared in the current decade. Despite the conventional nano drug delivery systems, we have proven the multiple drug loading affinity on carbon dots for the first time in history, which displayed a smaller particle size (3.5 nm), even after the drug loading. The pediatric glioblastoma cell viability experiments promisingly emphasized the higher anti-cancer efficacy of the multiple drug-loaded carbon dots with a lower dosage of drugs.

Notwithstanding carbon dots, we have even researched the highly photoluminescent carbon nitride dots as a promising nano-tool for pediatric brain tumors. Despite the brain tumors, carbon dots are promising bio-imaging tools for labeling bones/calcium-rich environments, which is beneficial to identify bone cancers or related bone disease in the early stages. Apart from the cancers or the bone-related research, we also research introducing carbon dots as a nano-tool for AD site identificatory or nano-carrier.

Even though the nano-drug delivery systems displayed a target specificity towards cancerous sites, identifying each tumor type is still challenging. Thus, our on-going research is currently based on identifying each tumor type and enhancing the target specificity of carbon dots or carbon nitride dots. Thus, our efforts are to provide toxic-free and less harmful solutions for the entire humankind.